Viewing nowFiora Tablet (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
iWorld Pharmaceuticals Co., Ltd.

MFDS item code 201502986 · Approved 2015.05.19 · Insurance code 669604380
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used along with diet and exercise to help control blood sugar in patients with Type 2 diabetes. It may also be used alone, but if its effectiveness is insufficient after using other blood sugar-lowering agents, it can be combined with sulfonylureas, metformin, or insulin. Additionally, nutritional counseling, weight loss, and regular exercise are crucial for patients with Type 2 diabetes. Such lifestyle improvements help maintain the effectiveness of medication therapy for a long time in addition to initial treatment. This medication is used to help patients effectively control their blood sugar.
This medicine is administered orally once daily, regardless of meals. 1. Monotherapy This medicine may be initiated at 15 mg once daily in patients whose blood glucose is not adequately controlled. If the effect is insufficient, the dose may be increased to 30 mg once daily. 2. Combination therapy - When used in combination with a sulfonylurea, the initial dose is 15 mg once daily. - When used in combination with metformin, the initial dose is 15 mg once daily. - When used in combination with insulin, administer 15 mg once daily. The maximum recommended dose should not exceed 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use.
This medication is used in the treatment of Type 2 diabetes, helping to control blood sugar by improving insulin resistance. When taking this medication, there is a risk of congestive heart failure, which may put stress on the heart, so patients should be closely monitored for symptoms of heart failure such as changes in weight, shortness of breath, and swelling after starting treatment. It is safest for patients with a history of heart failure or current heart failure symptoms to avoid this medication. This medication may cause fluid retention, which can lead to swelling or worsening of heart failure; thus, patients should consult healthcare providers immediately if swelling symptoms occur. Patients with bladder cancer or a history of bladder cancer should not take this medication, and they should inform their doctor immediately if they experience hematuria or urinary problems. Patients with poor liver function or severely impaired kidney function should also refrain from taking this medication. Patients should have regular blood sugar and liver function tests while taking this medication and report any unusual symptoms to their healthcare providers promptly. There is a risk of hypoglycemia; therefore, when taking insulin or other blood sugar-lowering medications together, patients should be cautious of hypoglycemic symptoms and adjust doses of other medications as needed. Pre-menopausal women should use appropriate contraception, as this medication may stimulate ovulation and increase the likelihood of pregnancy. Elderly patients, especially those over 75 years old, require more careful monitoring when taking this medication. In case of overdose, specific symptoms may not be present, but it is essential to consult a healthcare provider immediately for appropriate treatment. This medication has not been established for safety and efficacy in children; thus, it should not be used in this age group. When taking this medication, keep it out of reach of children and store it in its original container.
Congestive heart failure, excessive and rapid weight change, dyspnea, edema, fluid retention, inadequate blood sugar control, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, abdominal distension, weight gain, hypoglycemia, urinary tract infection, lumbago, dizziness, diarrhea, elevated serum creatine kinase, heart failure, limb pain, chest pain, death due to cardiovascular predisposition, hospitalization due to worsening congestive heart failure, emergency room visit due to congestive heart failure, adverse cardiovascular events, dizziness, increased blood sugar, elevated ALT/AST, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, dyspnea, itching, chest discomfort, tremors, chills, gastrointestinal disease, abdominal pain, epigastric discomfort, numbness, muscle rigidity, discomfort in the head, exacerbation of liver disease, urticaria, eczema, arthralgia, knee abnormalities, weakness in the arms, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, hypertension, heart failure, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, abdominal pain, heart failure, fractures, macular edema, bladder cancer
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that protects it from light and air. It is also advised to store it in a cool place, avoiding moist areas, at a temperature between 15 to 30 degrees Celsius. A temperature around 25 degrees Celsius is ideal.
Round and convex white to grayish-white tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
iWorld Pharmaceuticals Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.